All Stories

  1. Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis

    Article • PLOS One, March 2026, PLOS

    M.D.,Ph.D. Rubén Queiro

  2. Gene Variant in the NF-κB Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

    Article • BioMed Research International, November 2019, Hindawi Publishing Corporation

    M.D.,Ph.D. Rubén Queiro

  3. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis

    Article • The Journal of Rheumatology, February 2019, The Journal of Rheumatology

    M.D.,Ph.D. Rubén Queiro

  4. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Article • Annals of the Rheumatic Diseases, December 2018, BMJ

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  5. Registro Español de Artritis Psoriásica de Reciente Comienzo (estudio REAPSER). Objetivos y metodología

    Article • Reumatología Clínica, December 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  6. Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis

    Article • International Journal of Rheumatic Diseases, November 2018, Wiley

    M.D.,Ph.D. Rubén Queiro

  7. Biological Dose Tapering in Daily Clinical Practice: A 10 Year Follow-up Study

    Article • Reumatología Clínica, October 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  8. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis

    Article • JCR Journal of Clinical Rheumatology, October 2018, Wolters Kluwer Health

    M.D.,Ph.D. Rubén Queiro

  9. Recomendaciones de la Sociedad Española de Reumatología sobre el tratamiento y uso de terapias sistémicas biológicas y no biológicas en artritis psoriásica

    Article • Reumatología Clínica, September 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  10. Ustekinumab in psoriatic arthritis: need for studies from real-world evidence

    Article • Expert Opinion on Biological Therapy, July 2018, Taylor & Francis

    M.D.,Ph.D. Rubén Queiro

  11. Norma de calidad para el manejo del paciente con artritis psoriásica: proyecto QUANTUM

    Article • Reumatología Clínica, July 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  12. Recommendations for the Use of Methotrexate in Psoriatic Arthritis

    Article • Reumatología Clínica (English Edition), July 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  13. Remission and stringent treatment goals in psoriatic arthritis: Doctors’ opinion is not enough

    Article • Joint Bone Spine, July 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  14. Recomendaciones sobre el uso de metotrexato en pacientes con artritis psoriásica

    Article • Reumatología Clínica, July 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  15. Anti-MDA5 dermatomyositis mimicking psoriatic arthritis

    Article • Reumatología Clínica, July 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  16. Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature

    Article • Patient Preference and Adherence, May 2018, Dove Medical Press

    Marta Comellas, Professor Luis Lizan, M.D.,Ph.D. Rubén Queiro

  17. Prevalence and type II diabetes-associated factors in psoriatic arthritis

    Article • Clinical Rheumatology, February 2018, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  18. Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain

    Article • Rheumatology International, February 2018, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  19. Estado actual de la atención multidisciplinar para pacientes con artritis psoriásica en España: proyecto NEXUS 2.0

    Article • Reumatología Clínica, February 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  20. Enfermedad de Pyle: un modelo humano de homeostasis corticotrabecular diferenciada

    Article • Reumatología Clínica, February 2018, Elsevier

    M.D.,Ph.D. Rubén Queiro

  21. Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?

    Article • Clinical Rheumatology, January 2018, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  22. Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    M.D.,Ph.D. Rubén Queiro

  23. Recommendations for the management of comorbidity in hidradenitis suppurativa

    Article • Journal of the European Academy of Dermatology and Venereology, September 2017, Wiley

    M.D.,Ph.D. Rubén Queiro

  24. L’âge à l’apparition du rhumatisme psoriasique pourrait faciliter la caractérisation de son phénotype

    Article • Revue du Rhumatisme, July 2017, Elsevier

    M.D.,Ph.D. Rubén Queiro

  25. NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant

    Article • Human Immunology, May 2017, Elsevier

    M.D.,Ph.D. Rubén Queiro

  26. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study

    Article • March 2017, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  27. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España

    Article • Reumatología Clínica, March 2017, Elsevier

    M.D.,Ph.D. Rubén Queiro

  28. Multidisciplinary care for psoriatic disease

    Article • Rheumatology, January 2017, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  29. Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis

    Article • Joint Bone Spine, October 2016, Elsevier

    M.D.,Ph.D. Rubén Queiro

  30. Urine metabolome profiling of immune-mediated inflammatory diseases

    Article • BMC Medicine, September 2016, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  31. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

    Article • PLOS One, July 2016, PLOS

    M.D.,Ph.D. Rubén Queiro

  32. Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis

    Article • Clinical Rheumatology, May 2016, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  33. Common and rareCARD14gene variants affect the antitumour necrosis factor response among patients with psoriasis

    Article • British Journal of Dermatology, April 2016, Wiley

    M.D.,Ph.D. Rubén Queiro

  34. CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients

    Article • International Immunopharmacology, December 2015, Elsevier

    M.D.,Ph.D. Rubén Queiro

  35. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort.

    Article • Journal of Dermatological Science, November 2015, Elsevier

    M.D.,Ph.D. Rubén Queiro

  36. HLA-B27 and psoriatic disease: a modern view of an old relationship

    Article • Rheumatology, August 2015, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  37. Cardiovascular risk factors influence response to biological therapies in psoriasis

    Article • Journal of the American Academy of Dermatology, August 2015, Elsevier

    M.D.,Ph.D. Rubén Queiro

  38. AB0823 Age at Disease Onset Helps to Further Characterize the Disease Phenotype in Psoriatic Arthritis

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    M.D.,Ph.D. Rubén Queiro

  39. AB0824 Predictors of Cerebrovascular Disease Among Psoriatic Arthritis Patients

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    M.D.,Ph.D. Rubén Queiro

  40. AB1133 Epidemiological Comparative Analysis in a Large Cohort of Psoriatic Arthritis Patients: Results of the Spanish IMID Consortium

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    M.D.,Ph.D. Rubén Queiro

  41. A deletion atADAMTS9-MAGI1locus is associated with psoriatic arthritis risk

    Article • Annals of the Rheumatic Diseases, May 2015, BMJ

    Professor Josep Ll. Gelpi, M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  42. Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis

    Article • Clinical & Experimental Immunology, April 2015, Wiley

    M.D.,Ph.D. Rubén Queiro

  43. Reccomendations for the Detection, Study and Referral of Inflammatory Low-back Pain in Primary Care

    Article • Reumatología Clínica (English Edition), March 2015, Elsevier

    M.D.,Ph.D. Rubén Queiro

  44. Recomendaciones para la detección, investigación y derivación del dolor lumbar inflamatorio en Atención Primaria

    Article • Reumatología Clínica, March 2015, Elsevier

    M.D.,Ph.D. Rubén Queiro

  45. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients

    Article • Pharmacogenetics and Genomics, March 2015, Wolters Kluwer Health

    M.D.,Ph.D. Rubén Queiro

  46. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

    Article • Archives of Dermatological Research, December 2014, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  47. Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis

    Article • Arthritis Care & Research, November 2014, Wiley

    M.D.,Ph.D. Rubén Queiro

  48. Ankylosing Spondylitis without Axial Progression: Analysis of Associated Factors

    Article • The Journal of Rheumatology, November 2014, The Journal of Rheumatology

    M.D.,Ph.D. Rubén Queiro

  49. Comprehensive Treatment of Dactylitis in Psoriatic Arthritis

    Article • The Journal of Rheumatology, November 2014, The Journal of Rheumatology

    M.D.,Ph.D. Rubén Queiro

  50. PDE3A-SLCO1C1locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

    Article • Pharmacogenomics, November 2014, Future Medicine

    M.D.,Ph.D. Rubén Queiro

  51. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus

    Article • Journal of Dermatological Science, September 2014, Elsevier

    M.D.,Ph.D. Rubén Queiro

  52. Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with psoriasis

    Article • British Journal of Dermatology, August 2014, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  53. AB0736 Strategy for the Early Detection and Referral of Patients with Suspected Spondyloarthritis: Table 1

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    M.D.,Ph.D. Rubén Queiro

  54. AB0764 An Onset of Psoriasis after 40 Years and A Low Education Level May PREDICT the Development of Diabetes Mellitus in Psoriatic Arthritis

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    M.D.,Ph.D. Rubén Queiro

  55. SAT0410 Determinants of Hypertension in Patients with Psoriatic Arthritis

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    M.D.,Ph.D. Rubén Queiro

  56. Recommendations for the Coordinated Management of Psoriatic Arthritis by Rheumatologists and Dermatologists: A Delphi Study

    Article • Actas Dermo-Sifiliográficas (English Edition), April 2014, Elsevier

    M.D.,Ph.D. Rubén Queiro

  57. Standards of care for patients with spondyloarthritis

    Article • Rheumatology International, January 2014, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  58. The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis

    Article • ISRN Dermatology, January 2014, Hindawi Publishing Corporation

    M.D.,Ph.D. Rubén Queiro

  59. Age at disease onset: a key factor for understanding psoriatic disease

    Article • Rheumatology, November 2013, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  60. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis

    Article • British Journal of Dermatology, October 2013, Wiley

    M.D.,Ph.D. Rubén Queiro

  61. SNP rs11652075 in the CARD14 Gene as a Risk Factor for Psoriasis (PSORS2) in a Spanish Cohort

    Article • DNA and Cell Biology, October 2013, Mary Ann Liebert Inc

    M.D.,Ph.D. Rubén Queiro

  62. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Article • The Lancet, August 2013, Elsevier

    M.D.,Ph.D. Rubén Queiro, Dr Ronald Vender

  63. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Article • Reumatología Clínica, July 2013, Elsevier

    M.D.,Ph.D. Rubén Queiro

  64. Different Clinical Expression of Patients With Ankylosing Spondylitis According to Gender in Relation to Time Since Onset of Disease. Data From REGISPONSER

    Article • Reumatología Clínica (English Edition), July 2013, Elsevier

    M.D.,Ph.D. Rubén Queiro

  65. AB0588 Prevalence of conventional cardiovascular risk factors in patients with psoriasis alone and in patients with psoriatic arthritis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    M.D.,Ph.D. Rubén Queiro

  66. FRI0556 Development of standards of care in spondyloarthritis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    M.D.,Ph.D. Rubén Queiro

  67. SAT0311 Men and women with psoriatic arthritis express a different genetic profile within the major histocompatibility complex region

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    M.D.,Ph.D. Rubén Queiro

  68. Erosive discovertebral lesion (Andersson lesion) as the first sign of disease in axial psoriatic arthritis

    Article • Scandinavian Journal of Rheumatology, January 2013, Taylor & Francis

    M.D.,Ph.D. Rubén Queiro

  69. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  70. Dropped Head Syndrome in a Patient With Scleromyositis

    Article • JCR Journal of Clinical Rheumatology, January 2013, Wolters Kluwer Health

    M.D.,Ph.D. Rubén Queiro

  71. Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of Psoriasis

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    M.D.,Ph.D. Rubén Queiro

  72. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes

    Article • Cytokine, October 2012, Elsevier

    M.D.,Ph.D. Rubén Queiro

  73. Ustekinumab en la artritis psoriásica y la enfermedad de Crohn

    Article • Actas Dermo-Sifiliográficas, October 2012, Elsevier

    M.D.,Ph.D. Rubén Queiro

  74. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes

    Article • Human Molecular Genetics, July 2012, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro, M.D.,Ph.D. Rubén Queiro

  75. Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

    Article • Annals of the Rheumatic Diseases, June 2012, BMJ

    M.D.,Ph.D. Rubén Queiro

  76. Uso del cuestionario Hospital Anxiety and Depression Scale (HADS) para evaluar la ansiedad y la depresión en pacientes con fibromialgia

    Article • Revista de Psiquiatría y Salud Mental, April 2012, Elsevier

    M.D.,Ph.D. Rubén Queiro

  77. Actualización en la patogenia de la artritis psoriásica

    Article • Reumatología Clínica, March 2012, Elsevier

    M.D.,Ph.D. Rubén Queiro

  78. Entheseal ultrasound abnormalities in patients with SAPHO syndrome

    Article • Clinical Rheumatology, February 2012, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  79. A high density SNP genotyping approach within the 19q13 chromosome region identifies an association of a CNOT3 polymorphism with ankylosing spondylitis

    Article • Annals of the Rheumatic Diseases, January 2012, BMJ

    M.D.,Ph.D. Rubén Queiro, Dr Ana Maria Aransay

  80. Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern Spain

    Article • Rheumatology International, December 2011, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  81. Implantation d’un filtre cave inférieur dans le corps de la troisième vertèbre lombaire

    Article • Revue du Rhumatisme, December 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  82. HLA-DR17 est associé à une enthésite dans le rhumatisme psoriasique

    Article • Revue du Rhumatisme, December 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  83. La stratification par âge d’apparition de la maladie avec limite fixée à 30ans : une méthode efficace pour identifier le psoriasis associé à PSORS1 chez les patients atteints de rhumatisme psoriasique

    Article • Revue du Rhumatisme, December 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  84. Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis

    Article • Joint Bone Spine, December 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  85. Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas

    Article • Reumatología Clínica, September 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  86. Consensus Statement of the Spanish Society of Rheumatology on Risk Management of Biologic Therapy in Rheumatic Patients

    Article • Reumatología Clínica (English Edition), September 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  87. HLA-DR17 is associated with enthesitis in psoriatic arthritis

    Article • Joint Bone Spine, July 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  88. High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

    Article • Rheumatology, June 2011, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  89. Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica

    Article • Reumatología Clínica, May 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  90. Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis

    Article • Reumatología Clínica (English Edition), January 2011, Elsevier

    M.D.,Ph.D. Rubén Queiro

  91. Power Doppler Ultrasonography Assessment of Entheses in Spondyloarthropathies: Response to Therapy of Entheseal Abnormalities

    Article • The Journal of Rheumatology, September 2010, The Journal of Rheumatology

    M.D.,Ph.D. Rubén Queiro

  92. Comorbilidades en las espondiloartropatías

    Article • Seminarios de la Fundación Española de Reumatología, July 2010, Elsevier

    M.D.,Ph.D. Rubén Queiro

  93. Factors associated with temporary work disability in patients with fibromyalgia

    Article • Rheumatology International, May 2010, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  94. Mutation analysis of the LCE3B/LCE3C genes in Psoriasis

    Article • BMC Medical Genetics, March 2010, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  95. Terapias biológicas distintas de la terapia anti-TNFα en la psoriasis y la artritis psoriásica

    Article • Reumatología Clínica, March 2010, Elsevier

    M.D.,Ph.D. Rubén Queiro

  96. Determinants of psoriatic arthritis in patients with psoriasis

    Article • Expert Review of Dermatology, February 2010, Taylor & Francis

    M.D.,Ph.D. Rubén Queiro

  97. Development of a self-reporting tool to obtain a Combined Index of Severity of Fibromyalgia (ICAF*)

    Article • Health and Quality of Life Outcomes, January 2010, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  98. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

    Article • Rheumatology, July 2009, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  99. Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis

    Article • Joint Bone Spine, October 2008, Elsevier

    M.D.,Ph.D. Rubén Queiro

  100. L’expression clinique, contrairement aux paramètres évolutifs, peut varier selon l’âge de début de la maladie dans le rhumatisme psoriasique

    Article • Revue du Rhumatisme, October 2008, Elsevier

    M.D.,Ph.D. Rubén Queiro

  101. ¿Es útil el ejercicio en el tratamiento de la espondilitis anquilosante?

    Article • Seminarios de la Fundación Española de Reumatología, June 2008, Elsevier

    M.D.,Ph.D. Rubén Queiro

  102. May Some Cases of Intermittent Hydrarthrosis Represent an Atypical Form of Calcium Pyrophosphate Dihydrate Crystal Deposition Disease? Usefulness of Mutational Analysis of the MEFV Gene

    Article • Seminars in Arthritis and Rheumatism, February 2008, Elsevier

    M.D.,Ph.D. Rubén Queiro

  103. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility

    Article • Rheumatology, January 2007, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  104. An unexpectedly high frequency ofMEFV mutations in patients with anti–citrullinated protein antibody–negative palindromic rheumatism

    Article • Arthritis & Rheumatism, January 2007, Wiley

    M.D.,Ph.D. Rubén Queiro

  105. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Article • Reumatología Clínica, May 2006, Elsevier

    M.D.,Ph.D. Rubén Queiro

  106. Tratamientos en artritis reumatoide precoz

    Article • Seminarios de la Fundación Española de Reumatología, March 2006, Elsevier

    M.D.,Ph.D. Rubén Queiro

  107. Article • Arthritis Research & Therapy, January 2006, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  108. Association of intermittent hydrarthrosis withMEFV gene mutations

    Article • Arthritis & Rheumatism, January 2006, Wiley

    M.D.,Ph.D. Rubén Queiro

  109. Tratamientos no biológicos en la artritis psoriásica

    Article • Reumatología Clínica, July 2005, Elsevier

    M.D.,Ph.D. Rubén Queiro

  110. The effect of HLA‐DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis

    Article • Scandinavian Journal of Rheumatology, October 2004, Taylor & Francis

    M.D.,Ph.D. Rubén Queiro

  111. RS3PE syndrome: a clinical and immunogenetical study

    Article • Rheumatology International, March 2004, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  112. Successful therapy with low-dose colchicine in intermittent hydrarthrosis

    Article • Rheumatology, February 2003, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro

  113. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

    Article • Annals of the Rheumatic Diseases, January 2003, BMJ

    M.D.,Ph.D. Rubén Queiro

  114. Spectrum of psoriatic spondyloarthropathy in a cohort of 100 Spanish patients

    Article • Annals of the Rheumatic Diseases, September 2002, BMJ

    M.D.,Ph.D. Rubén Queiro

  115. Successful Treatment with Low-Dose Weekly Methotrexate in a Case of Undifferentiated Spondyloarthropathy coexisting with Cutaneous Polyarteritis Nodosa

    Article • Clinical Rheumatology, August 2002, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  116. C4 deficiency state in antiphospholipid antibody-related recurrent preeclampsia evolving into systemic lupus erythematosus

    Article • Rheumatology International, July 2002, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  117. Psoriatic spondyloarthropathy: A comparative study between HLA-B27 positive and HLA-B27 negative disease

    Article • Seminars in Arthritis and Rheumatism, June 2002, Elsevier

    M.D.,Ph.D. Rubén Queiro

  118. Clinical features and predictive factors in psoriatic arthritis–related uveitis

    Article • Seminars in Arthritis and Rheumatism, February 2002, Elsevier

    M.D.,Ph.D. Rubén Queiro

  119. Clinically Asymptomatic Axial Disease in Psoriatic Spondyloarthropathy. A Retrospective Study

    Article • Clinical Rheumatology, February 2002, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  120. Prevalence and Predictors of Cervical Involvement in Psoriatic Spondyloarthropathy

    Article • JCR Journal of Clinical Rheumatology, February 2002, Wolters Kluwer Health

    M.D.,Ph.D. Rubén Queiro

  121. Comparative analysis of psoriatic spondyloarthropathy between men and women

    Article • Rheumatology International, October 2001, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  122. Manifestaciones atípicas de la enfermedad de Whipple

    Article • Anales de Medicina Interna, January 2001, Instituto de Salud Carlos III/BNCS/SciELO Espana

    M.D.,Ph.D. Rubén Queiro

  123. Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study

    Article • Clinical Rheumatology, November 2000, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  124. Haematogenous Vertebral Osteomyelitis in the Elderly

    Article • Clinical Rheumatology, August 2000, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro

  125. Multiple painful bone cysts in a young man.

    Article • Annals of the Rheumatic Diseases, June 1996, BMJ

    M.D.,Ph.D. Rubén Queiro

  126. Psoriatic Arthropathy after BCG Immunotherapy for Bladder Carcinoma

    Article • Rheumatology, January 1995, Oxford University Press (OUP)

    M.D.,Ph.D. Rubén Queiro